News Headlines Article

FDA starts first part of transparency initiative
Modern Healthcare - Shawn Rhea

The Food and Drug Administration has launched the first phase of its three-part transparency initiative, which aims to provide consumers and other stakeholders with a better understanding of how the agency and its medical-products approval processes operate. “This initiative will make information about the FDA more user-friendly and accessible to the public,” FDA Commissioner Margaret Hamburg said in a news release.